Clinical trials we fund
Clinical trials are research studies involving people. They test various aspects of new drugs, treatment regiments, and/or lifestyle changes.
There are two main types of clinical trials: interventional or observational. Interventional trials test a particular intervention such as new drugs or treatment regimens; whereas, observational studies aim to find out what happens to people in different situations.
Clinical trials are vital as they rigorously test new treatments to see if they are safe and effective before it becomes widely available.
The Brain Tumour Charity are committed to advancing research in the field of brain tumours and we fund a range of clinical trials including testing new therapies and treatment regimens, as well as interventions to improve quality of life.
Find out about the clinical trials currently investing in by The Brain Tumour Charity.
PNET5 trial: Medulloblastoma
This trial aims to improve the quality of survival by providing kinder and tailored treatments.
Tessa Jowell: BRAIN-MATRIX
This trial will enable doctors to treat brain tumours with drugs that are more targeted.
We’re funding the UK participation of BIOMEDE, an adaptive clinical trial for children with DMG (DIPG).
The first trial that will evaluate the impact of low grade tumours and their treatment in children.
Studying the potential of two drugs to treat young people with low grade gliomas.
Analysing over 1,200 samples, to determine if there are further tumour subtypes.
A grant to enable new analysis of an ongoing international clinical trial to impact on future trials.
A quality of life trial that will evaluate the use of lifestyle and behavioural changes as a way to manage fatigue.
Using new imaging technology to to visualise and measure protein build-up in low-grade diffuse gliomas.
Developing a supported self-management programme to improve quality-of-life